Phencyclidine Antibodies

Santa Cruz Biotechnology offers a broad range of Phencyclidine Antibodies for various research applications. Phencyclidine Antibodies are optimized for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Phencyclidine, commonly known as PCP, is a dissociative anesthetic that affects the NMDA receptor and induces psychotomimetic effects. Understanding Phencyclidine in neuropharmacology is crucial for research into its impact on the central nervous system and potential therapeutic applications. The study of Phencyclidine plays a vital role in substance abuse research, particularly regarding its effects on behavior and cognition. Monoclonal Phencyclidine antibodies enable precise detection and quantification in biological samples, supporting comprehensive analysis of drug metabolism and distribution. Advanced research techniques incorporating Phencyclidine monoclonal antibodies help identify cellular targets and pathways affected by PCP exposure. Santa Cruz Biotechnology monoclonal Phencyclidine antibodies contribute to advancing neuroscience research and developing improved therapeutic strategies.